维普期刊资源整合服务平台（V6.5）

91篇 您的检索式：作者名="Filipski E"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Improved tumor control through circadian clock induction by seliciclib, a cyelin-dependent kinase inhibitor显示文摘	Iurisci I Filipski E Reinhardt J	2006	Cancer Res2006，66，10：	1
2	Host circadian clock as a control point in tumor propression 显示文摘	Filipski E King VM Li X	2002	J Natl Cancer Inst2002，94，9：	1
3	Experimental Chronotherapy of Mouse Mammary Adenocarcinoma MA13/C with docetaxel and Doxorubicine as Single Agent and in Combination显示文摘	Filipski E D'Attino RM	2001	Cancer Res2001，61，5：	1
4	Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicine as single agent and in combination 显示文摘	Grande T G Filipski E D'Attino R M	2002	Chronobiol Int2002，19，10：	1
5	Docelaxel chronopharmacology in mice显示文摘	Tampellini M Filipski E Liu XH	1998	Cancer Res1998，58，1：	1
6	Host circadian clock as a control point in tumor propression显示文摘	Filipski E King VM Li X	2002	J Natl Cancer Inst2002，94，9：	1
7	Rosenlund B,Circadianexpression of clock genes in purified hematopoietic stem cellsis developmentally regulated in mouse bone marrow显示文摘	Tsinkalovsky O Filipski E	2006	ExpHematol2006，34，9：	1
8	Experimental Chronotherapy of Mouse Mammary Adenocarcinoma MA13/C with doeetaxel and Doxorubicine as Single Agent and in Combinarion 显示文摘	Granda TG Filipski E D'Attino RM	2001	Cancer Res2001，61，5：	1
9	Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine:relationship with cisplatin toxicity in mice显示文摘	Li XM Metzger G Filipski E		0，，：	1
10	Circadian Optimization of Irinotecan and Oxaliplatin Efficacy in Mice with Glasgow Osteosarcoma显示文摘	D'attino RM Filipski E	2002	Br J Cancer2002，86，6：	1
11	Relationship between circadian rhythm of Vinorelbine toxicity and efficacy in P388-bearing mice显示文摘	Amat S Lemaigre G	1999	J Phannacol Exp Ther1999，289，1：	1
12	Nanosatellite navigation with the WMM2005 geomagnetic field model显示文摘	FiliPski M N Abdullah E J		0，，01：	1
13	Disruption of circadian coordination and malignant growth 显示文摘	Filipski E Li XM Levi F	2006	Cancer Causes Control2006，17，4：	1
14	Circadian optimisation of irinotecan and oxaliplantin efficacy in mice with Glasgow osteosarcoma 显示文摘	Granda TG Dattino RM Filipski E	2002	Br J Cancer2002，86，6：	1
15	Host circadian clock as a control point in tumor progression显示文摘	Filipski E King VM Li X		0，，：	1
16	Docetaxel chronopharmacology in mice 显示文摘	Tampellini M Filipski E Liu XH	1998	Cancer Res1998，58，170：	1
17	Relationship between circadian rhythm of vinorelbine toxicity and efficacy in P388-bearing mice 显示文摘	Filipski E Amat S Lemaigre G	1999	J Pharmacol Exp Ther1999，289，1：	1
18	Modeling the welfare impacts of agriettltural pelieies in developing eotmtries 显示文摘	Jonasson E Filipski M Brooks J and Taylor J E	2014	Journal of Policy Modeling2014，36，：	1
19	Disruption of circadian coordination and malignant growth显示文摘	FILIPSKI E LI X M LEVI F	2006	Cancer Causes Control2006，17，4：	1
20	Host circadian clock as a control point in tumor progression显示文摘	King V M Li X M	2002	Journal of the National Cancer Institute2002，94，9：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示